KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Nu Skin Enterprises (NUS) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Nu Skin Enterprises' Liabilities and Shareholders Equity fell 1001.26% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year decrease of 1474.81%. This contributed to the annual value of $1.5 billion for FY2024, which is 1878.29% down from last year.
  • As of Q3 2025, Nu Skin Enterprises' Liabilities and Shareholders Equity stood at $1.4 billion, which was down 1001.26% from $1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Nu Skin Enterprises' Liabilities and Shareholders Equity peaked at $2.0 billion during Q2 2021, and registered a low of $1.4 billion during Q1 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $1.8 billion (2023), whereas its average is $1.7 billion.
  • As far as peak fluctuations go, Nu Skin Enterprises' Liabilities and Shareholders Equity surged by 1423.73% in 2021, and later plummeted by 2012.18% in 2025.
  • Quarter analysis of 5 years shows Nu Skin Enterprises' Liabilities and Shareholders Equity stood at $1.9 billion in 2021, then fell by 4.49% to $1.8 billion in 2022, then decreased by 0.68% to $1.8 billion in 2023, then decreased by 18.78% to $1.5 billion in 2024, then fell by 3.03% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.4 billion during Q1 2025.